Skip to content
Wenlo
Sign in
← Markets

Boston Scientific Corp.

Boston Scientific Corp. (BSX) — Form 8-K: Current report

8-KBSXFiled Nov 17, 2026, 4:08 PM ET· Period Nov 17, 2026

AI-generated summary

Boston Scientific Corp. filed a current report announcing executive compensation and board changes on November 17, 2026. The board approved the 2027 Annual Bonus Plan and two performance share programs for executive officers. Additionally, the independent directors appointed David S. Wichmann as Lead Independent Director, effective January 1, 2027, succeeding Edward J. Ludwig.

Key facts

  • Item 5.02 · Executive or director change or pay arrangement
  • Item 8.01 · Other events
  • Item 9.01 · Financial statements and exhibits

More BSX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.